ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)

Proud to join @who.int ’s new GCTF to advance equitable, ethical & impactful research worldwide. Together with NUS SSHSPH, ADVANCE-ID will help strengthen Asia’s trial ecosystems - training local teams, innovating designs & fostering collaboration.

🔗 Read more: ad-id.co/GCTF

NUS Medicine has received a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support DETECT-Asia (Strengthening Diagnostics for sEvere bacTErial infeCTions in Asia) to enhance the #diagnostics for severe bacterial infections and fight #AMR. ad-id.co/gpr

ADVANCE-ID Directors make presentations at the inaugural Global AMR Innovators Conference (GAMRIC), London, October 1 and 2, 2025.

Read more: ad-id.co/a1

#GAMRIC2025

💭 How do we make the most of the funding that we have available for #AMR? Innovation AND evaluation of impact. Development AND implementation in real life have to be thought at the same time.

#GAMRIC2025 @carb-x.bsky.social @lifearc.bsky.social @gardp.bsky.social @advance-id.bsky.social #IDSky

🌍 Passionate about Clinical Microbiology & #AMR? Join us in our #Microbiology Interest Group! We would love to connect with #microbiologists, ID physicians, fellows, lab staff & managers - All levels of experience are welcome!

📩 Contact Dr Alec Aligui: alec.aligui@u.nus.edu

#physicians #clinical

✨ We’re excited to have Dr Xiong Beibei join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

🚀 Exciting news!

Registration is now open for #ACC2026- a *FREE* virtual conference co-organized by GARDP & British Society for Antimicrobial Chemotherapy, joined this year by ADVANCE-ID & Mahidol University.

📅 4 & 5 February 2026

Don’t miss out!

🔗Register here: bit.ly/467KGKa

✨ We’re excited to have Dr Nguyen Thi Kim Anh join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

🚨Last week to comment! WHO’s draft TPPs for new antibacterial agents are open for public consultation until 7 Sep 2025. Feedback is particularly encouraged on the special considerations for children in TPPs 2 & 3.

Share your input: bit.ly/3JPzDwh

Related blogpost: bit.ly/4g2zhOR

✨We’re excited to have Dr Alec Aligui join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

✨We’re excited to have Dr Bao Qiongling join the ADVANCE-ID team! Get to know her in this short introduction.

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

Big milestone for the Promoting Community Engagement for Clinical Trials in Asia project. We just held our first Scientific Advisory Board Meeting! 🌟 Read more: ad-id.co/cep1

📅 Save the Date: ACC2026

The Antimicrobial Chemotherapy Conference (ACC2026) is coming your way in February 2026!

This year, GARDP and British Society for Antimicrobial Chemotherapy are teaming up with ADVANCE-ID and Mahidol University to develop this online conference.

🚀 Join us in welcoming Dr Iris Chang to the ADVANCE-ID team! Here’s a brief introduction to get to know her better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

🚀 Join us in welcoming Dr Luca Mezzadri to the ADVANCE-ID team! Here’s a brief introduction to get to know him better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

We are pleased to announce that earlier this month, we enrolled the first patient into the CRGNB silo of the TREAT-GNB platform trial! TREAT-GNB was also recently initiated at another two hospital centres in China. Read more: ad-id.co/t1

🚀 Join us in welcoming Dr Abi Manesh to the ADVANCE-ID team! Here’s a brief introduction to get to know him better!

#WelcomeOnboard #ADVANCE_ID #AMR #ClinicalTrials #Research #Singapore

A new episode in the RESISTALKs podcast series is out! Dive into the BEATLE trial on extended vs bolus β-lactam infusions for febrile neutropenia in haematology patients.

Access the episode here: ad-id.co/4eBkytq

#AMR #RESISTALKs

✨ We’re excited to share that our Health Economics Interest Group had its very first meet up session yesterday! Thank you to all who joined us as we kicked off a journey into the economics of #InfectiousDiseases & #AMR.

Interested get involved? Drop us an email: mdcmy@nus.edu.sg

#HealthEconomics

📖 Check out "The AMR Diary" developed by The Antimicrobial Resistance (AMR) Diary team from Universiti Malaya (Malaysia)! This book shines a light on the often-overlooked personal stories behind the global challenge of #AMR.

👉 Read & share: bit.ly/4kHQf6M

#AMRWISE360 #FreeOnlineAccess #AMRDiary

Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID. 

Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia:
tinyurl.com/infex-advanc...

#infex #ClinicalResearch #AMR

Today, we join the global community in celebrating #ClinicalTrialsDay, recognising the vital role that clinical trials play in advancing medical science and improving patient care, honoring the power and purpose of all clinical research professionals. #CTD2025 #AMR #ClinicalTrials #GlobalHealth

Join the upcoming #Ecraid Webinar “Adaptive Trials: From Theory to Practice”
Date: 10 July 2025
Time: 11am-12pm CEST|5pm-6pm SGT

The webinar will have six 2-hour online modules, offering practical insights into adaptive clinical trials. Register now: lnkd.in/gdtEjPMK

#AdaptiveTrials #ClinicalTrial

We’re setting up a Health Economics Interest Group at ADVANCE-ID and we’re looking for collaborators to join us! ✅ Clinicians, pharmacists, microbiologists ✅ Investigators, research fellows ✅ Any level of experience Interested? Email to Dr. Mo Yin at mdcmy@nus.edu.sg

We’re setting up a Health Economics Interest Group at ADVANCE-ID and we’re looking for collaborators to join us!

✅ Clinicians, pharmacists, microbiologists
✅ Investigators, research fellows
✅ Any level of experience

Interested? Email to Dr. Mo Yin at mdcmy@nus.edu.sg
#HealthEconomics #AMR #Health

🎙️ Join this upcoming webinar on 22 May 2025, which will showcase the importance of clinical trials after licensing antibiotics by demonstrating two major trials taking place.

Register now: lnkd.in/gsqVQCKZ

AMR is a deadly reality requiring urgent, coordinated action. ADVANCE-ID contributed to the latest AMR report through ACORN-HAI, highlighting the importance of hospital-based surveillance in the fight against drug resistance. Access the full report: bit.ly/amr-report

We're hiring! Join us as a Research Fellow (Clinical Trial Community Engagement) at ADVANCE-ID!

📢 We're hiring! Join us as a Research Fellow (Clinical Trial Community Engagement) at ADVANCE-ID!

📌 Conduct research on risk communication, public perceptions, attitudes & community engagement in clinical trial settings in Asia.

📩 Apply now: tinyurl.com/rfctce

#Hiring #JobOpening #JoinOurTeam

MORU-OUCRU Discovery Research Academy (MODRA) applications are now open! An 18-mth programme for early to mid-career postdocs, with expert-led training, mentorship & funding to advance your career in global health & infectious diseases! Find out more: www.oucru.org/modra/
#MORU #OUCRU #MODRA

🚀 What an incredible start to the 2nd ADVANCE-ID Network Symposium! A huge thank you to everyone of you who joined us today. 🎉

🔗 Explore the rest of our exciting program: tinyurl.com/49t272uw

Stay tuned and join us for more groundbreaking discussions on infectious diseases!

This week, we were honoured to have had an exchange session for the sharing of insights with professionals from The First Affiliated Hospital, Zhejiang University School of Medicine, China.